US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Santorius AG (PK) (SSSGY) 銘柄情報

Santorius AG (PK) (SSSGY)

43.9325

0.00

(0.00%)

終了 7月13日 5:00AM

Santorius AG (PK) (SSSGY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

43.9325

( - )

買値

24.96

売値

70.88

出来高

-

平均取引量 (3 か月)

US$ 96,848

財務取引量

-

0.00 日の範囲 0.00

37.87 52 週間の範囲 50.95

時価総額

企業価値

19.193B

前日終値

43.9325

始値

-

時刻

最終取引時間

VWAP

-

歳入

3.55B

純利益

162.6M

発行済株式数

69,038,196

浮動株比率 (%)

39.76%

機関投資家保有比率 (%)

14.66%

配当利回り

0.74 (0.34%)

PER

-

株価売上高倍率 (PSR)

4.02

1 株当たり利益 (EPS)

-

ベータ

1.47

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and ... Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.sartorius.com

本社

Göttingen, Germany

設立

1870

Santorius AG (PK) is listed in the sector of the その他OTC with ticker SSSGY. The last closing price for Santorius (PK) was US$43.93. Over the last year, Santorius (PK) shares have traded in a share price range of US$ 37.87 to US$ 50.95.

Santorius (PK) currently has 69,038,196 shares in issue. The market capitalisation of Santorius (PK) is US$3.03 billion.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	1.8325	4.35273159145	42.1	44.68	42.1	405	43.89895833	DR
26	-3.9375	-8.22540213077	47.87	49.77	39.454	392	44.63284489	DR
52	4.8825	12.5032010243	39.05	50.95	37.87	309	44.37269318	DR
156	-11.0675	-20.1227272727	55	55	36.43	246	44.25072777	DR
260	-68.8175	-61.0354767184	112.75	199	36.43	229	56.36633287	DR

SSSGY - Frequently Asked Questions (FAQ)

What is the current Santorius AG (PK) share price?

The current share price of Santorius AG (PK) is US$ 43.9325

How many Santorius AG (PK) shares are in issue?

Santorius AG (PK) has 69,038,196 shares in issue

What is the market cap of Santorius AG (PK)?

The market capitalisation of Santorius AG (PK) is USD 3.03B

What is the 1 year trading range for Santorius AG (PK) share price?

Santorius AG (PK) has traded in the range of US$ 37.87 to US$ 50.95 during the past year

What is the cash to sales ratio of Santorius AG (PK)?

The cash to sales ratio of Santorius AG (PK) is 4.02

What is the registered address of Santorius AG (PK)?

The registered address for Santorius AG (PK) is Otto-Brenner-Strasse 20, Göttingen, Lower Saxony, 37079

What is the Santorius AG (PK) website address?

The website address for Santorius AG (PK) is www.sartorius.com

Truthsocial

Truthsocial 2分前

Yes, preliminary trial results for Vivos Inc (RDGL) in India are available and have been publicly reported, but comprehensive final data is still pending.

Safety and Efficacy Data: Reports from early 2025 confirm that ten patients with cancerous lymph nodes were successfully treated

Biotech_Tradez

Biotech_Tradez 5分前

Heard Electrome was not happy with Mayer on a number of different fronts.

They were not very keen on this deal with BIEL because it is a distraction from what they are doing with their own patent-pending device that was invented by the new CEO. He is taking it to DARPA for funding. On

shajandr

shajandr 13分前

SAM ALTMAN = LIZZY HOLMES with better hair.

ron_66271

ron_66271 15分前

The Discovery Document by QE Proves RICO.

Project West.

The BOD was reviewed on the status of the project three times from the discovery document.
Therefore the BOD past and present are compliant if current members have not voiced their concerns about settlement

Porch Honkey

Porch Honkey 18分前

When they are ready, there will be investors here that you have never seen before, gl.

LOB

Blaqclouds Wyoming

@blaqclouds_WY
#Blaqclouds • #DEFI💎 http://BLAQpay.io http://AplloNFT.io🔎• #NFT #WEB3 Dev • DM 📩 for Collab
Social Media InfluencerPAblaqclouds.io
Joined May 2020
1,260 Following
123.5K Followers

Juststoppingby

Juststoppingby 23分前

My AI responds to clarification on “EDGAR packages are being validated”.

When I say “EDGAR packages are being validated,” I’m talking about a very specific, very technical stage in the SEC-filing process — one that happens right before a delinquent filer begins submitting forms.

zakattack

zakattack 24分前

They put out a pr dec 2025 stating they would increase to 49% in gncp but no filings proving they actually did so sp again where is the proof pdiv paid anything or did anything for the land claims prove me wrong

nowwhat2

nowwhat2 27分前

xxxxxxxxxxxx wow

https://investorshub.advfn.com/uimage/uploads/2026/7/13/i[smibtc_july_12_2m_7pm_200_64_diag_point.jpg

https://investorshub.advfn.com/uimage/uploads/2026/7/13/wtzkebtc_july_12_2m_9pm_update_200_64_point_tl.jpg

mikeo56

mikeo56 29分前

Smoking in Aussie land .
Up 30 %
Tomorrow in USA will be good.

choo choo trader

choo choo trader 32分前

Thanks for reposting it Striper, somehow I missed it when gdog initially posted it. That is about the most informative video I have seen so far laying out the whole risk/reward story of $NLST.

ron_66271

ron_66271 33分前

No The FDIC and JPM both Had a Claim Against $24 Billion.

Inflated claim of $27*2=$54.00 Billion against the Estate to make WMI as insolvent for the Senior Note holders when JPM controlled the BK process because invested in the Senior Notes of WMI with the takeover.

skitahoe

skitahoe 33分前

Doc, I've been saying this for ages, but not that the full EDEN based facility must be completed. I believe the UK and other countries would simply like to know it's close. They'd like to know the EDEN is making commercial quality vaccine and that it can be delivered in quantity, and they'd like t

FDA-agent-2

FDA-agent-2 37分前

nobody is getting paid here .no editiing or no research which cost money.

Johnnycombat10

Johnnycombat10 38分前

I see both sides of the debate . The company has every right to state their position just as you have your right to speak yours. But you have right to demand anything from anyone on this board. You have no rights other than the right to speak our mind. And I have the to tell you to pound salt. If I

AstroGuru64

AstroGuru64 39分前

The issue still lies with the Treasury Department.

FDA-agent-2

FDA-agent-2 42分前

too much fake news on facebook, yahoo,and youtube these. and tabloid news or censored news.
sites like google, yahoo. facebook cannot get the content for cheap anymore or they won't even license it to them, it used to be free or very cheap to promote their newsight but they don't nobody ever

Truthsocial

Truthsocial 45分前

Vivos Inc. received U.S. FDA approval for the Investigational Device Exemption (IDE) for RadioGel® on July 6, 2026, which permits the initiation of the first-in-human feasibility study at Mayo Clinic in Jacksonville, FL.

While the FDA IDE approval has been granted, the study protocol

gfp927z

gfp927z 45分前

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

uber darthium

uber darthium 45分前

DBSCAM’em

A Linda Poory SCAM for over 2 decades

Can’t wait to read that filing this week

Ought to make for some good SCAM reading

DBSCAM’em

Noted and Always Correct

zerosnoop

zerosnoop 46分前

All the GEMS & FACTS are in the latest 10Q filing. The PROVEN AOT is going GLOBAL.

We are now focusing on a potential sale of 150 units as an initial purchase order under the so-called Laksel LOI (discussed below). This represents a defined India focused initial program wit

gfp927z

gfp927z 47分前

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

raggi65

raggi65 48分前

Do you have a link to the discovery document filed by Quinn Emanuel?
825 pages – that sounds as though there might be plenty of useful arguments in there, and with a citable reference, they would be all the more compelling

juicyjuice10002

juicyjuice10002 51分前

Yes, Executive Order 14393 is widely expected to help Fannie Mae (FNMA) and Freddie Mac (FMCC) by laying the regulatory groundwork for their eventual exit from government conservatorship.

While much of the public text targets community banks, the order contains specific directives fo

Deutsche Bank Luxembourg

China Merchants Hai Hong (PK)

Hman Unitec (EM)

Medical Connections (EM)

Invesco Markets

Satus 21-1.28 C

Jackson Financial

Gunpoint Exploration (PK)

VanEck Investments

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。